SPACInsider Logo
Pono Capital (PONO) Terminates Benuvia Deal
by Marlena Haddad on 2022-08-10 at 6:12pm

Pono Capital (NASDAQ:PONO) announced this afternoon that it has mutually terminated its combination with cannabinoid drug developer Benuvia.

While today’s press release did not provide much detail, Pono Capital intends to continue its search for a target for its business combination and extended its transaction timeline today by three months. The SPAC originally had a deadline of August 13, 2022, but will now have until November 11, 2022 to find a new target and close.

Pono raised $100 million at IPO on August 11, 2021 and initially set out to combine with a disruptive technology company in China or Japan in the area of consumer electronics. The tech-focused SPAC is led by CEO and Founder Dustin Shindo, Chief Strategy Officer Dr. Hank Wuh and CFO Trisha Nomura.

CEO and Founder Dustin Shindo is also Chairman of Pono Capital Two (NASDAQ:PTWOU), one of six SPACs that filed to IPO in June. Pono Capital Two priced its $100 million IPO just last week on August 4, and intends to also focus on disruptive tech targets in Japan.

The termination comes several months after the $440 million deal announcement, which was originally announced on March 18. Pono’s deal with Benuvia was not supplemented with a PIPE and did not have a minimum cash closing condition. The Arizona-based company owns an FDA approved cannabinoid drug SYNDROS (dronabinol oral solution CII), and synthetic cannabinoid manufacturing facilities in the U.S.



Recent Posts
by Kristi Marvin on 2023-01-28 at 1:59pm

Terms Tracker for the Week Ending January 27, 2022 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. We’re coming up on the end of January, the first month of the year, and to-date no new S-1s have been filed. Additionally, the number...

by Marlena Haddad on 2023-01-27 at 11:34am

  Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC News: Circle spokesperson denies blaming SEC for failed deal, BuzzFeed CEO says AI-powered content will be part of core business, and FaZe Clan faces possible delisting Circle Spokesperson Denies Blaming SEC for Failed $9 Billion Deal...

by Nicholas Alan Clayton on 2023-01-27 at 10:00am

Health Sciences 2 (NASDAQ:HSAQ) announced that it closed its combination with Orchestra BioMed on January 26. HSAQ ahead of its vote pre-announced redemption figures of 1,597,888 shares equating to 67.7% redemptions, however, that’s still subject to change.  However, today it was noted that Orchestra BioMed is to receive $70 million in gross proceeds including $20...

by Kristi Marvin on 2023-01-27 at 7:33am

Carbon capture technology has long been talked about, and it is finally in operation with LanzaTech among the pioneers. Its plants are turning potential emissions into clothing, household goods and sustainable fuels. SPAC cash is now also an accelerant in this new process as the company announced a $1.7 billion combination with AMCI II last March. This week, we caught up with...

by Nicholas Alan Clayton on 2023-01-27 at 7:30am

In this series we’ll be examining successful SPAC deals from the past both in the terms and circumstances of their de-SPAC processes and how they have weathered the storms that have followed after their public listings with research from SPACInsider contributor Anthony Sozzi. Thirty months does not sound like that long, but it’s been a...

Privacy Policy|Terms Of Use
Copyright © 2022 SPACInsider, Inc. All Rights Reserved